Structure

Physi-Chem Properties

Molecular Weight:  314.08
Volume:  308.569
LogP:  2.054
LogD:  1.76
LogS:  -3.312
# Rotatable Bonds:  2
TPSA:  104.06
# H-Bond Aceptor:  6
# H-Bond Donor:  3
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.733
Synthetic Accessibility Score:  3.473
Fsp3:  0.176
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.874
MDCK Permeability:  8.788802006165497e-06
Pgp-inhibitor:  0.005
Pgp-substrate:  0.956
Human Intestinal Absorption (HIA):  0.009
20% Bioavailability (F20%):  0.016
30% Bioavailability (F30%):  0.004

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.029
Plasma Protein Binding (PPB):  95.75458526611328%
Volume Distribution (VD):  0.49
Pgp-substrate:  3.867116928100586%

ADMET: Metabolism

CYP1A2-inhibitor:  0.232
CYP1A2-substrate:  0.526
CYP2C19-inhibitor:  0.529
CYP2C19-substrate:  0.064
CYP2C9-inhibitor:  0.805
CYP2C9-substrate:  0.977
CYP2D6-inhibitor:  0.627
CYP2D6-substrate:  0.661
CYP3A4-inhibitor:  0.611
CYP3A4-substrate:  0.232

ADMET: Excretion

Clearance (CL):  18.147
Half-life (T1/2):  0.889

ADMET: Toxicity

hERG Blockers:  0.05
Human Hepatotoxicity (H-HT):  0.225
Drug-inuced Liver Injury (DILI):  0.806
AMES Toxicity:  0.059
Rat Oral Acute Toxicity:  0.304
Maximum Recommended Daily Dose:  0.541
Skin Sensitization:  0.794
Carcinogencity:  0.104
Eye Corrosion:  0.009
Eye Irritation:  0.897
Respiratory Toxicity:  0.136

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC202112

Natural Product ID:  NPC202112
Common Name*:   Phayomphenol A1
IUPAC Name:   (3R,4S)-3-acetyl-5,7-dihydroxy-4-(4-hydroxyphenyl)-3,4-dihydroisochromen-1-one
Synonyms:   Phayomphenol A1
Standard InCHIKey:  ULVDXYXKRNQCCO-HOCLYGCPSA-N
Standard InCHI:  InChI=1S/C17H14O6/c1-8(18)16-14(9-2-4-10(19)5-3-9)15-12(17(22)23-16)6-11(20)7-13(15)21/h2-7,14,16,19-21H,1H3/t14-,16-/m0/s1
SMILES:  Oc1ccc(cc1)[C@@H]1[C@@H](OC(=O)c2c1c(O)cc(c2)O)C(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1939274
PubChem CID:   57391943
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003411] 2-benzopyrans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26194 Shorea roxburghii Species Dipterocarpaceae Eukaryota Barks n.a. n.a. PMID[22209731]
NPO26194 Shorea roxburghii Species Dipterocarpaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT462 Individual Protein Sucrase-isomaltase Rattus norvegicus IC50 > 400000.0 nM PMID[506675]
NPT462 Individual Protein Sucrase-isomaltase Rattus norvegicus Inhibition = 6.4 % PMID[506675]
NPT32 Organism Mus musculus Mus musculus Inhibition = 189.3 % PMID[506675]
NPT32 Organism Mus musculus Mus musculus Inhibition = 199.5 % PMID[506675]
NPT32 Organism Mus musculus Mus musculus Inhibition = 159.2 % PMID[506675]
NPT32 Organism Mus musculus Mus musculus Inhibition = 184.1 % PMID[506675]
NPT32 Organism Mus musculus Mus musculus Inhibition = 178.1 % PMID[506675]
NPT32 Organism Mus musculus Mus musculus Inhibition = 166.2 % PMID[506675]
NPT671 Individual Protein Acidic alpha-glucosidase Rattus norvegicus IC50 > 400000.0 nM PMID[506675]
NPT671 Individual Protein Acidic alpha-glucosidase Rattus norvegicus Inhibition = 4.0 % PMID[506675]
NPT68 Individual Protein Aldose reductase Rattus norvegicus IC50 = 39800.0 nM PMID[506675]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC202112 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC51513
0.9521 High Similarity NPC125487
0.9521 High Similarity NPC281703
0.9375 High Similarity NPC81835
0.9021 High Similarity NPC155205
0.8951 High Similarity NPC52358
0.8828 High Similarity NPC53649
0.8828 High Similarity NPC244923
0.8811 High Similarity NPC301915
0.8811 High Similarity NPC261292
0.88 High Similarity NPC56204
0.88 High Similarity NPC470107
0.875 High Similarity NPC478200
0.875 High Similarity NPC191835
0.875 High Similarity NPC472602
0.875 High Similarity NPC33144
0.8742 High Similarity NPC230848
0.8741 High Similarity NPC235115
0.8733 High Similarity NPC77325
0.8733 High Similarity NPC84142
0.8733 High Similarity NPC4423
0.8725 High Similarity NPC476463
0.8723 High Similarity NPC476389
0.8716 High Similarity NPC131766
0.8707 High Similarity NPC478202
0.8699 High Similarity NPC478217
0.8699 High Similarity NPC313123
0.8699 High Similarity NPC472035
0.8699 High Similarity NPC472603
0.8699 High Similarity NPC478201
0.8693 High Similarity NPC208173
0.8693 High Similarity NPC170189
0.8693 High Similarity NPC472890
0.8693 High Similarity NPC478221
0.869 High Similarity NPC88269
0.8684 High Similarity NPC76041
0.8684 High Similarity NPC184284
0.8681 High Similarity NPC71256
0.8681 High Similarity NPC70380
0.8675 High Similarity NPC164762
0.8675 High Similarity NPC295036
0.8658 High Similarity NPC470570
0.8649 High Similarity NPC478203
0.8649 High Similarity NPC42540
0.8649 High Similarity NPC126882
0.8649 High Similarity NPC151607
0.8649 High Similarity NPC193703
0.8649 High Similarity NPC21599
0.8649 High Similarity NPC48762
0.8649 High Similarity NPC210966
0.863 High Similarity NPC472601
0.863 High Similarity NPC472600
0.8627 High Similarity NPC478231
0.8621 High Similarity NPC212693
0.8621 High Similarity NPC94248
0.8618 High Similarity NPC295650
0.8618 High Similarity NPC91809
0.8609 High Similarity NPC477941
0.8609 High Similarity NPC80370
0.8591 High Similarity NPC184649
0.8591 High Similarity NPC257558
0.8591 High Similarity NPC303185
0.8591 High Similarity NPC34482
0.8591 High Similarity NPC83272
0.8581 High Similarity NPC472006
0.8581 High Similarity NPC472889
0.8581 High Similarity NPC159721
0.8581 High Similarity NPC478225
0.8581 High Similarity NPC354984
0.8571 High Similarity NPC158634
0.8571 High Similarity NPC472605
0.8571 High Similarity NPC317585
0.8571 High Similarity NPC472604
0.8571 High Similarity NPC69043
0.8571 High Similarity NPC478230
0.8571 High Similarity NPC99381
0.8562 High Similarity NPC268052
0.8562 High Similarity NPC474843
0.8562 High Similarity NPC161159
0.8562 High Similarity NPC115249
0.8553 High Similarity NPC472891
0.8543 High Similarity NPC215711
0.8543 High Similarity NPC94781
0.8543 High Similarity NPC172329
0.8543 High Similarity NPC73411
0.8543 High Similarity NPC221352
0.8543 High Similarity NPC2569
0.8542 High Similarity NPC27407
0.8533 High Similarity NPC472033
0.8533 High Similarity NPC268366
0.8533 High Similarity NPC107625
0.8533 High Similarity NPC299011
0.8531 High Similarity NPC153783
0.8523 High Similarity NPC113770
0.8523 High Similarity NPC471906
0.8521 High Similarity NPC198249
0.8516 High Similarity NPC227062
0.8514 High Similarity NPC49108
0.8514 High Similarity NPC250755
0.8514 High Similarity NPC137649
0.8506 High Similarity NPC137301
0.8503 High Similarity NPC158472
0.8497 Intermediate Similarity NPC92747
0.8497 Intermediate Similarity NPC215921
0.8497 Intermediate Similarity NPC265862
0.8497 Intermediate Similarity NPC39819
0.8497 Intermediate Similarity NPC70016
0.8493 Intermediate Similarity NPC472403
0.8493 Intermediate Similarity NPC9121
0.8493 Intermediate Similarity NPC177307
0.8493 Intermediate Similarity NPC221104
0.8487 Intermediate Similarity NPC120171
0.8483 Intermediate Similarity NPC291454
0.8477 Intermediate Similarity NPC259632
0.8477 Intermediate Similarity NPC77903
0.8477 Intermediate Similarity NPC210320
0.8477 Intermediate Similarity NPC17101
0.8477 Intermediate Similarity NPC472036
0.8471 Intermediate Similarity NPC24627
0.8471 Intermediate Similarity NPC471744
0.8467 Intermediate Similarity NPC472034
0.8467 Intermediate Similarity NPC311144
0.8466 Intermediate Similarity NPC171706
0.8462 Intermediate Similarity NPC478190
0.8456 Intermediate Similarity NPC202981
0.8456 Intermediate Similarity NPC51106
0.8456 Intermediate Similarity NPC471731
0.8456 Intermediate Similarity NPC472610
0.8456 Intermediate Similarity NPC73028
0.8456 Intermediate Similarity NPC469542
0.8456 Intermediate Similarity NPC310340
0.8446 Intermediate Similarity NPC1704
0.8446 Intermediate Similarity NPC470842
0.8446 Intermediate Similarity NPC67650
0.8442 Intermediate Similarity NPC167903
0.8442 Intermediate Similarity NPC478224
0.8438 Intermediate Similarity NPC477517
0.8435 Intermediate Similarity NPC32360
0.8435 Intermediate Similarity NPC92655
0.8435 Intermediate Similarity NPC105456
0.8435 Intermediate Similarity NPC275356
0.8435 Intermediate Similarity NPC86744
0.8435 Intermediate Similarity NPC19622
0.8435 Intermediate Similarity NPC139634
0.8435 Intermediate Similarity NPC112789
0.8431 Intermediate Similarity NPC267117
0.8431 Intermediate Similarity NPC225854
0.8425 Intermediate Similarity NPC65837
0.8425 Intermediate Similarity NPC178467
0.8425 Intermediate Similarity NPC474771
0.8425 Intermediate Similarity NPC149372
0.8425 Intermediate Similarity NPC474849
0.8421 Intermediate Similarity NPC153417
0.8421 Intermediate Similarity NPC39195
0.8418 Intermediate Similarity NPC112418
0.8414 Intermediate Similarity NPC142027
0.8411 Intermediate Similarity NPC473023
0.8411 Intermediate Similarity NPC267509
0.8408 Intermediate Similarity NPC470339
0.8403 Intermediate Similarity NPC472591
0.84 Intermediate Similarity NPC184702
0.84 Intermediate Similarity NPC470216
0.84 Intermediate Similarity NPC470932
0.8392 Intermediate Similarity NPC219892
0.8392 Intermediate Similarity NPC189823
0.8392 Intermediate Similarity NPC214702
0.8392 Intermediate Similarity NPC470831
0.8389 Intermediate Similarity NPC471733
0.8389 Intermediate Similarity NPC18714
0.8389 Intermediate Similarity NPC474385
0.8389 Intermediate Similarity NPC297985
0.8389 Intermediate Similarity NPC103752
0.8389 Intermediate Similarity NPC469579
0.8387 Intermediate Similarity NPC203080
0.8378 Intermediate Similarity NPC254994
0.8378 Intermediate Similarity NPC275903
0.8377 Intermediate Similarity NPC221249
0.8377 Intermediate Similarity NPC205918
0.8377 Intermediate Similarity NPC471229
0.8369 Intermediate Similarity NPC209959
0.8367 Intermediate Similarity NPC475974
0.8367 Intermediate Similarity NPC197666
0.8367 Intermediate Similarity NPC126739
0.8366 Intermediate Similarity NPC306343
0.8366 Intermediate Similarity NPC44378
0.8366 Intermediate Similarity NPC280753
0.8366 Intermediate Similarity NPC476684
0.8366 Intermediate Similarity NPC270160
0.8366 Intermediate Similarity NPC277032
0.8366 Intermediate Similarity NPC9099
0.8366 Intermediate Similarity NPC247219
0.8366 Intermediate Similarity NPC237440
0.8365 Intermediate Similarity NPC471745
0.8355 Intermediate Similarity NPC142863
0.8355 Intermediate Similarity NPC308200
0.8355 Intermediate Similarity NPC52106
0.8355 Intermediate Similarity NPC119767
0.8355 Intermediate Similarity NPC5568
0.8354 Intermediate Similarity NPC472055
0.8354 Intermediate Similarity NPC155101

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC202112 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8387 Intermediate Similarity NPD7819 Suspended
0.8344 Intermediate Similarity NPD7075 Discontinued
0.8322 Intermediate Similarity NPD3750 Approved
0.8311 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8269 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8188 Intermediate Similarity NPD1549 Phase 2
0.8165 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8151 Intermediate Similarity NPD230 Phase 1
0.8121 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8121 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8108 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8108 Intermediate Similarity NPD1510 Phase 2
0.8105 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8089 Intermediate Similarity NPD1934 Approved
0.8069 Intermediate Similarity NPD3764 Approved
0.8039 Intermediate Similarity NPD6799 Approved
0.8038 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD5844 Phase 1
0.8 Intermediate Similarity NPD3749 Approved
0.7988 Intermediate Similarity NPD7473 Discontinued
0.7987 Intermediate Similarity NPD2533 Approved
0.7987 Intermediate Similarity NPD2534 Approved
0.7987 Intermediate Similarity NPD3748 Approved
0.7987 Intermediate Similarity NPD2532 Approved
0.7987 Intermediate Similarity NPD3817 Phase 2
0.7975 Intermediate Similarity NPD6801 Discontinued
0.7962 Intermediate Similarity NPD4380 Phase 2
0.7962 Intermediate Similarity NPD6599 Discontinued
0.7959 Intermediate Similarity NPD1240 Approved
0.7937 Intermediate Similarity NPD3882 Suspended
0.7925 Intermediate Similarity NPD1465 Phase 2
0.7914 Intermediate Similarity NPD6232 Discontinued
0.7911 Intermediate Similarity NPD7411 Suspended
0.7908 Intermediate Similarity NPD6190 Approved
0.7904 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7875 Intermediate Similarity NPD5402 Approved
0.7875 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7867 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7853 Intermediate Similarity NPD6959 Discontinued
0.7852 Intermediate Similarity NPD1607 Approved
0.7838 Intermediate Similarity NPD943 Approved
0.7821 Intermediate Similarity NPD1512 Approved
0.7818 Intermediate Similarity NPD6166 Phase 2
0.7818 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7818 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7815 Intermediate Similarity NPD2935 Discontinued
0.7815 Intermediate Similarity NPD2796 Approved
0.7811 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7786 Intermediate Similarity NPD9545 Approved
0.7778 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7763 Intermediate Similarity NPD2346 Discontinued
0.7759 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7733 Intermediate Similarity NPD8150 Discontinued
0.7711 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7703 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7702 Intermediate Similarity NPD2801 Approved
0.7692 Intermediate Similarity NPD7390 Discontinued
0.7692 Intermediate Similarity NPD1511 Approved
0.7692 Intermediate Similarity NPD6797 Phase 2
0.7683 Intermediate Similarity NPD5494 Approved
0.7679 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7673 Intermediate Similarity NPD3226 Approved
0.7673 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD5403 Approved
0.7647 Intermediate Similarity NPD7251 Discontinued
0.7643 Intermediate Similarity NPD5401 Approved
0.7619 Intermediate Similarity NPD3818 Discontinued
0.7619 Intermediate Similarity NPD3751 Discontinued
0.7613 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD4628 Phase 3
0.7607 Intermediate Similarity NPD7768 Phase 2
0.7603 Intermediate Similarity NPD1470 Approved
0.7602 Intermediate Similarity NPD7808 Phase 3
0.7582 Intermediate Similarity NPD1551 Phase 2
0.7582 Intermediate Similarity NPD5404 Approved
0.7582 Intermediate Similarity NPD5406 Approved
0.7582 Intermediate Similarity NPD5405 Approved
0.7582 Intermediate Similarity NPD6100 Approved
0.7582 Intermediate Similarity NPD6099 Approved
0.7582 Intermediate Similarity NPD5408 Approved
0.7572 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7531 Intermediate Similarity NPD37 Approved
0.7529 Intermediate Similarity NPD7074 Phase 3
0.7517 Intermediate Similarity NPD9269 Phase 2
0.7516 Intermediate Similarity NPD2799 Discontinued
0.7515 Intermediate Similarity NPD6234 Discontinued
0.75 Intermediate Similarity NPD4966 Approved
0.75 Intermediate Similarity NPD4965 Approved
0.75 Intermediate Similarity NPD4967 Phase 2
0.7485 Intermediate Similarity NPD5711 Approved
0.7485 Intermediate Similarity NPD5710 Approved
0.7485 Intermediate Similarity NPD7229 Phase 3
0.7483 Intermediate Similarity NPD4060 Phase 1
0.7483 Intermediate Similarity NPD9268 Approved
0.7471 Intermediate Similarity NPD7054 Approved
0.7467 Intermediate Similarity NPD3268 Approved
0.7448 Intermediate Similarity NPD1201 Approved
0.7442 Intermediate Similarity NPD6559 Discontinued
0.7438 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD920 Approved
0.7434 Intermediate Similarity NPD6355 Discontinued
0.7427 Intermediate Similarity NPD7472 Approved
0.741 Intermediate Similarity NPD919 Approved
0.7405 Intermediate Similarity NPD7236 Approved
0.7397 Intermediate Similarity NPD1608 Approved
0.7394 Intermediate Similarity NPD9493 Approved
0.7391 Intermediate Similarity NPD8319 Approved
0.7391 Intermediate Similarity NPD8320 Phase 1
0.7389 Intermediate Similarity NPD7003 Approved
0.7381 Intermediate Similarity NPD3787 Discontinued
0.7375 Intermediate Similarity NPD6273 Approved
0.7365 Intermediate Similarity NPD2797 Approved
0.7362 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7351 Intermediate Similarity NPD6798 Discontinued
0.7351 Intermediate Similarity NPD2313 Discontinued
0.7346 Intermediate Similarity NPD7458 Discontinued
0.7337 Intermediate Similarity NPD7435 Discontinued
0.7333 Intermediate Similarity NPD4288 Approved
0.7333 Intermediate Similarity NPD4908 Phase 1
0.7329 Intermediate Similarity NPD1610 Phase 2
0.7325 Intermediate Similarity NPD2800 Approved
0.7321 Intermediate Similarity NPD7199 Phase 2
0.7312 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD7228 Approved
0.7308 Intermediate Similarity NPD2344 Approved
0.7308 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD1283 Approved
0.729 Intermediate Similarity NPD4308 Phase 3
0.7283 Intermediate Similarity NPD5953 Discontinued
0.7278 Intermediate Similarity NPD6535 Approved
0.7278 Intermediate Similarity NPD6534 Approved
0.7278 Intermediate Similarity NPD8166 Discontinued
0.7267 Intermediate Similarity NPD7286 Phase 2
0.7257 Intermediate Similarity NPD8313 Approved
0.7257 Intermediate Similarity NPD8312 Approved
0.7248 Intermediate Similarity NPD3267 Approved
0.7248 Intermediate Similarity NPD1164 Approved
0.7248 Intermediate Similarity NPD3266 Approved
0.7248 Intermediate Similarity NPD1203 Approved
0.7237 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD8434 Phase 2
0.7219 Intermediate Similarity NPD1247 Approved
0.7215 Intermediate Similarity NPD1243 Approved
0.7208 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD2798 Approved
0.7192 Intermediate Similarity NPD17 Approved
0.719 Intermediate Similarity NPD6663 Approved
0.719 Intermediate Similarity NPD6233 Phase 2
0.7188 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD1876 Approved
0.7178 Intermediate Similarity NPD7239 Suspended
0.7174 Intermediate Similarity NPD6782 Approved
0.7174 Intermediate Similarity NPD6779 Approved
0.7174 Intermediate Similarity NPD6777 Approved
0.7174 Intermediate Similarity NPD6776 Approved
0.7174 Intermediate Similarity NPD6778 Approved
0.7174 Intermediate Similarity NPD6781 Approved
0.7174 Intermediate Similarity NPD6780 Approved
0.7158 Intermediate Similarity NPD7699 Phase 2
0.7158 Intermediate Similarity NPD7700 Phase 2
0.7153 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD5736 Approved
0.7151 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1613 Approved
0.7143 Intermediate Similarity NPD2979 Phase 3
0.7143 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7685 Pre-registration
0.7135 Intermediate Similarity NPD3926 Phase 2
0.7135 Intermediate Similarity NPD5242 Approved
0.7126 Intermediate Similarity NPD5353 Approved
0.7125 Intermediate Similarity NPD3887 Approved
0.7125 Intermediate Similarity NPD2309 Approved
0.7125 Intermediate Similarity NPD2354 Approved
0.7122 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD6832 Phase 2
0.7105 Intermediate Similarity NPD7874 Approved
0.7105 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD5124 Phase 1
0.7097 Intermediate Similarity NPD447 Suspended
0.7097 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD422 Phase 1
0.7095 Intermediate Similarity NPD1281 Approved
0.7095 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD7266 Discontinued
0.7089 Intermediate Similarity NPD1471 Phase 3
0.707 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD7033 Discontinued
0.7059 Intermediate Similarity NPD7698 Approved
0.7059 Intermediate Similarity NPD7696 Phase 3
0.7059 Intermediate Similarity NPD7697 Approved
0.7059 Intermediate Similarity NPD4625 Phase 3
0.7056 Intermediate Similarity NPD4287 Approved
0.7053 Intermediate Similarity NPD8151 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data